Results 341 to 350 of about 218,065 (393)

Platelet Aggregation Inhibitors

Encyclopedia of Molecular Pharmacology, 2021

semanticscholar   +1 more source

ChemInform Abstract: SUBSTITUTED 3,4‐PENTADIENYLDIAMINES AS INHIBITORS OF PLATELET AGGREGATION

Chemischer Informationsdienst, 1973
AbstractKondensation der Allenaldehyde (III) mit den Diaminen (IV) und nachfolgende Reduktion der Schiffschen‐Basen (V) in situ mit Kaliumborhydrid liefern die Pentadienyldiamine (VI), die auf ihre Wirkung als Hemmstoffe der Blutblättchen‐Aggregation untersucht werden.
Thomas R. Blohm, Grisar Jm, R. D. Mackenzie, C. H. Tilford   +3 more
openaire   +4 more sources

2,3-Diphosphoglycerate: A Physiological Inhibitor of Platelet Aggregation

Science, 1975
2,3-Diphosphoglycerate (2,3-DPG) may inhibit the platelet release reaction and the irreversible aggregation of human blood platelets induced by adenosine diphosphate, epinephrine, or norepinephrine. The effects of 2,3-DPG on platelet aggregation were more pronounced in cases with low hematocrit (< 30 percent).
Sotirios G. Iatridis, Panayotis G. Iatridis, S.G. Markidou, Barth H. Ragatz   +3 more
openaire   +3 more sources

PLATELET AGGREGATION INHIBITOR IN GARLIC [PDF]

The Lancet, 1981
Susumu Oshiba, Terumi Tamada, Toyohiko Ariga   +2 more
openaire   +2 more sources

Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation

Biochemical and Biophysical Research Communications, 1970
Phosphorylase activity in suspension of human platelets was assayed prior to and following addition of thrombin and epinephrine which aggregate platelets prostaglandin E1 and E2 and adenosine cyclic 35 monophosphate which inhibit aggregation or sodium fluoride and isoproterenol which alter adenine nucleotide metabolism.
Sidney M. Wolfe, Albert B. Deisseroth, N R Shulman   +2 more
openaire   +4 more sources

Chapter 7. Platelet Aggregation Inhibitors

1971
Publisher Summary This chapter presents an overview of the platelet aggregation inhibitors. The therapeutic approach to thromboembolic disease is based on the inhibition of platelet aggregation. The use of fibrinolytic agents for the dissolution of thrombi and the prophylactic use of anticoagulants for their prevention has been known for some time ...
openaire   +2 more sources

New Platelet Aggregation Inhibitors [PDF]

Hämostaseologie, 1997
R. Verhaeghe, J. Vermylen
openaire   +1 more source

Non‐peptide‐based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies

Archiv der Pharmazie, 2018
P. K. Jaiswal, Vashundhra Sharma, Surendra Kumar, M. Mathur, A. K. Swami, D. Yadav, S. Chaudhary   +6 more
semanticscholar   +1 more source

Design, synthesis and QSAR study of arylidene indoles as anti-platelet aggregation inhibitors

Medicinal Chemistry Research, 2015
S. S. Mirfazli, M. Khoshneviszadeh, Mohammad Jeiroudi, A. Foroumadi, F. Kobarfard, A. Shafiee   +5 more
semanticscholar   +1 more source

Effect of sustained use of platelet aggregation inhibitors on post‐endoscopic sphincterotomy bleeding

Digestive Endoscopy, 2014
Min Geun Lee, Jaihwan Kim, S. Lee, B. Lee, Seung June Lee, Yoon Suk Lee, B. Cha, Jin-Hyeok Hwang, J. Ryu, Yong-Tae Kim   +9 more
semanticscholar   +1 more source